Horizon Therapeutics shares owned by UBS O'Connor
Quarter-by-quarter ownership of Horizon Therapeutics shares owned by UBS O'Connor
from 13F filings
Historical chart of UBS O'Connor investment in Horizon Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Horizon Therapeutics held by UBS O'Connor consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Horizon Therapeutics by UBS O'Connor
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $887M | 7.7M | 115.69 |
| 2023-03-31 | $434M | 4.0M | 109.14 |
| 2022-12-31 | $260M | 2.3M | 113.80 |
| 2022-09-30 | $4.6M | 74k | 61.89 |
| 2022-06-30 | $6.3M | 79k | 79.76 |
| 2022-03-31 | $2.6M | 25k | 105.20 |
Top funds holding Horizon Therapeutics
View all funds holding Horizon Therapeutics